1.7 semaglutide to tirzepatide vs. Tirzepatide: Which GLP-1 Is Right for You? Switching from semaglutide to tirzepatide
Description
Some cases require feeding tubes, ongoing medical treatment, or result in permanent dietary restrictions
Burns, it becomes a powerful tool for achieving sustainable, long-term weight loss
If these medications are required, other medications to reduce the risk of ulcer formation may be prescribed
Other gastrointestinal sensations include: Feeling of fullness or early satiety after eating smaller portions than usual Mild abdominal discomfort or bloating Diarrhea (reported in 12-22% of patients, dose-dependent) Constipation (7-17% of patients, dose-dependent) Vomiting (2-10% of patients) Dyspepsia or gastroesophageal reflux symptoms Decreased appetite (reported in up to 27% of patients) Appetite and eating pattern changes represent another prominent category of sensations
Your membership includes Everything you Need, one Simple Plan One membership
Wegovy EPAR public assessment report (PDF)
